Presentation is loading. Please wait.

Presentation is loading. Please wait.

Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective.

Similar presentations


Presentation on theme: "Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective."— Presentation transcript:

1 Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial  Vaishali Sanchorawala, Dina Brauneis, Anthony C. Shelton, Stephen Lo, Fangui Sun, J. Mark Sloan, Karen Quillen, David C. Seldin  Biology of Blood and Marrow Transplantation  Volume 21, Issue 8, Pages (August 2015) DOI: /j.bbmt Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

2 Figure 1 (A) Study design. (B) Treatment algorithm and consort diagram. Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions

3 Figure 2 OS and PFS by Kaplan-Meier analysis with 95% confidence intervals (dotted lines). Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt ) Copyright © 2015 American Society for Blood and Marrow Transplantation Terms and Conditions


Download ppt "Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective."

Similar presentations


Ads by Google